Review of Advanced Biliary Cancer Treatments 🌟

Created using ChatSlide

This lecture will provide an in-depth overview of advanced biliary cancer treatments, drawing on current clinical landscape insights. We will explore first-line therapies, including Cisplatin and Gemcitabine in the ABC-02 study and the integration of Durvalumab from the TOPAZ-1 trial. Second-line strategies will cover FOLFOX outcomes, IDH1 mutation-targeted therapies, and novel advancements. Furthermore, we'll delve into cutting-edge targeted treatments for FGFR, HER2, and BRAF mutations. The...